KEAP1 and cancer: Response to oxidative stress could be used to study the treatment of lung adenocarcinoma, for example, KEAP1/NRF2 mutation was a major gene subtype of lung adenocarcinoma, which activated endogenous oxidative stress response and underwent significant metabolic recombination to support enhanced antioxidant generation to treat cancer (20).